Publications
Print PDF
Patent Cap in Drug Pricing Bill Seen as Having Muted Effect
July 25, 2024
Ryan Davis
Law360

Axinn partner Ted Mathias was quoted in the Law360 article, "Patent Cap in Drug Pricing Bill Seen as Having Muted Effect."

Click here to access the publication, a subscription is required. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.